Bengaluru: Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a ...
Eligible people in the Black Country are being reminded to come forward for the respiratory syncytial virus (RSV) vaccine.
The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...
Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.
As we navigate through flu season and the ongoing challenges of respiratory illnesses, it’s crucial to prioritize our health and well-being. One of the most effective ways to do this ...
Public Health Sudbury and Districts said Friday that outbreaks of respiratory and gastrointestinal illness are on the rise. Higher levels of sickness are being reported for influenza and enteric ...
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Hundreds of thousands of older people in the South East will receive RSV vaccine invites. The NHS is urging those aged 75-79, or who turned 80 after September 1, 2024, to book their vaccination ...
Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...
Dr. Smith is the president of the Tennessee Chapter of the American Academy of Pediatrics.
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...